FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Liothyronine Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 7 USDMF, 3 CEP/COS, 1 JDMF, 2 EU WC, 1 KDMF, 7 NDC API, 6 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

FINISHED DOSAGE FORMULATIONS

60 FDF Dossiers, 28 FDA Orange Book, 15 Europe, 8 Canada, 3 Australia, 3 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 0.005MG BASE, TABLET;ORAL - EQ 0.025MG BASE, TABLET;ORAL - EQ 0.05MG BASE, INJECTABLE;INJECTION - EQ 0.01MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 18 SPI Pharma, 4 Gangwal Healthcare, 2 Pfanstiehl, 5 Kirsch Pharma, 4 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 6 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 11 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 28 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

56 Fillers, Diluents & Binders, 40 Coating Systems & Additives, 26 Direct Compression, 19 Thickeners and Stabilizers, 19 Lubricants & Glidants, 19 Taste Masking, 18 Chewable & Orodispersible Aids, 15 Controlled & Modified Release, 15 Granulation, 12 Co-Processed Excipients, 12 Disintegrants & Superdisintegrants, 10 Parenteral, 9 Empty Capsules, 8 Film Formers & Plasticizers, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Solubilizers, 2 Topical, 2 Rheology Modifiers, 2 Coloring Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 28 News #PharmaBuzz

GLOBAL SALES INFORMATION

9 US Medicaid Prescriptions, 16 Regulatory FDF Prices

MARKET PLACE

17 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 4 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

TABLET;ORAL - EQ 0.005MG BASE

TABLET;ORAL - EQ 0.025MG BASE

TABLET;ORAL - EQ 0.05MG BASE

INJECTABLE;INJECTION - EQ 0.01MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Liothyronine Sodium

Liothyronine Sodium

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

17 API Suppliers

7 USDMF

3 CEP/COS

1 JDMF

2 EU WC

1 KDMF

7 NDC API

6 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

7 Drugs in Development

FINISHED DOSAGE FORMULATIONS

60 FDF Dossiers

28 FDA Orange Book

15 Europe

8 Canada

3 Australia

3 South Africa

3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 0.005MG BASE

TABLET;ORAL - EQ 0.025MG BASE

TABLET;ORAL - EQ 0.05MG BASE

INJECTABLE;INJECTION - EQ 0.01MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

18 SPI Pharma

4 Gangwal Healthcare

2 Pfanstiehl

5 Kirsch Pharma

4 ACG Worldwide

2 Actylis

1 Aeon Procare

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

5 BASF

10 Corel Pharma Chem

2 DFE Pharma

6 Gangwal Chemicals

4 Ideal Cures

3 Ingredion Pharma Solutions

11 Kerry

1 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

2 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

1 Novo Excipients

1 Pharmatrans-Sanaq

4 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

28 Roquette

7 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

3 Silverline Chemicals

2 The Dow Chemical Company

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

56 Fillers, Diluents & Binders

40 Coating Systems & Additives

26 Direct Compression

19 Thickeners and Stabilizers

19 Lubricants & Glidants

19 Taste Masking

18 Chewable & Orodispersible Aids

15 Controlled & Modified Release

15 Granulation

12 Co-Processed Excipients

12 Disintegrants & Superdisintegrants

10 Parenteral

INJECTABLE;INJECTION - EQ 0.01MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons